Back

Prediction of mode of death in patients with chronic heart failure by cardiac I-123 metaiodobenzylguanidine imaging :A prospective comparative study with the mode of end-stage liver disease score

30 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 7 - Heart failure / Left ventricular dysfunction Prognosis ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Eiji Fukuhara

Hyogo College of Medicine, Nishinomiya (Japan)

49 More presentations in this session

Presentation thumbnail
Professor H. Duengen (Berlin, DE)
Presentation thumbnail
Doctor T. Mondritzki (Wuppertal, DE)
Abstract Slides
Presentation thumbnail
Doctor A. Ruwald (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Associate Professor N. Ermis (Malatya, TR)
Abstract Slides
Presentation thumbnail
Professor S. Nie (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Poster session 7 - Heart failure / Left ventricular dysfunction

The Event

Event poster

ESC Congress 2016

30 August 2016 14:00 CET
You may be interested in
thumbnail
Congress Presentation
3 September 2019
thumbnail
Congress Session
Cardiac evaluation and follow-up with echo, in liver disease
29 August 2026
thumbnail
Congress Presentation
Prediction of mortality and mode of death by multimorbidity and clinical risk score systems in patients with heart failure: A nationwide analysis
21 May 2022
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources